Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems. The global market for highly potent active pharmaceutical ingredients (HPAPIs) has been growing ...
The use of antibodies as delivery vehicles for drug payloads in antibody–drug conjugates (ADCs) and simplified variants of traditional antibody models (i.e., nanobodies) are particularly versatile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback